CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability
- DOI
- 10.1186/s12943-026-02757-9
- Published
- 2026-08-07
- Container
- Molecular Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12943-026-02757-9,
title = {CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability},
author = {Antti Matvere and Gregory Menchon and Laetitia Martinetti and Amelie Menant and Loan Callac and Hugo Ferrari and Ulrich Jarry and Mathilde Gourdel and Aurelien Bore and Morgane Chassignolle and Victor Le Bars and Edouard Cadieu and Thomas Derrien and Marc Aubry and David Gilot and Remy Pedeux},
year = {2026},
journal = {Molecular Cancer},
doi = {10.1186/s12943-026-02757-9},
url = {https://doi.org/10.1186/s12943-026-02757-9}
}RIS
TY - JOUR TI - CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability AU - Antti Matvere AU - Gregory Menchon AU - Laetitia Martinetti AU - Amelie Menant AU - Loan Callac AU - Hugo Ferrari AU - Ulrich Jarry AU - Mathilde Gourdel AU - Aurelien Bore AU - Morgane Chassignolle AU - Victor Le Bars AU - Edouard Cadieu AU - Thomas Derrien AU - Marc Aubry AU - David Gilot AU - Remy Pedeux PY - 2026 JO - Molecular Cancer DO - 10.1186/s12943-026-02757-9 UR - https://doi.org/10.1186/s12943-026-02757-9 ER -
APA
Matvere, A., Menchon, G., Martinetti, L., Menant, A., Callac, L., Ferrari, H., Jarry, U., Gourdel, M., Bore, A., Chassignolle, M., Bars, V. L., Cadieu, E., Derrien, T., Aubry, M., Gilot, D., & Pedeux, R. (2026). CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability. Molecular Cancer. https://doi.org/10.1186/s12943-026-02757-9
Source records
- crossref · retrieved 2026-11-07T15:05:36.295Z